Certified by Founder Lodge
Longevity Vision Fund
United States - New York, New York
INVESTOR
1 Disclosed Funding Rounds $300,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Longevity Vision Fund (LVF) is a venture capital fund that invests in technologies with the potential to disrupt life sciences and healthcare to help people live longer, healthier lives. The
| Company | Date | Round | Raised |
|---|---|---|---|
 Tessera Therapeutics |
April, 19 ,2022 | Series C | $300,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Humand | $66,000,000 | (Feb 24, 2026)
Turgo.ai | $1,000,000 | (Feb 24, 2026)
Solid (AI for Data) | $20,000,000 | (Feb 24, 2026)
Freeform | $67,000,000 | (Feb 24, 2026)
Comeryx | $7,500,000 | (Feb 24, 2026)
